Cargando…
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy
Paclitaxel (PTX) has shown pleiotropic immunologic effects on the tumor microenvironment, and nanomicelle has emerged as a promising strategy for PTX delivery. However, the detailed mechanisms remain to be fully elucidated. Meanwhile, immunogenic cell death (ICD) is an effective approach to activate...
Autores principales: | Yang, Qianmei, Shi, Gang, Chen, Xiaolei, Lin, Yi, Cheng, Lin, Jiang, Qingyuan, Yan, Xi, Jiang, Ming, Li, Yiming, Zhang, Hantao, Wang, Huiling, Wang, Yuan, Wang, Qingnan, Zhang, Yujing, Liu, Yi, Su, Xiaolan, Dai, Lei, Tang, Minghai, Li, Jia, Zhang, Lan, Qian, Zhiyong, Yu, Dechao, Deng, Hongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381738/ https://www.ncbi.nlm.nih.gov/pubmed/32724476 http://dx.doi.org/10.7150/thno.45391 |
Ejemplares similares
-
Reduction-Sensitive
Dual Functional Nanomicelles for
Improved Delivery of Paclitaxel
por: Zhang, Xiaolan, et al.
Publicado: (2014) -
A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b
por: Wang, Huiling, et al.
Publicado: (2019) -
Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins
por: Li, Chunlei, et al.
Publicado: (2018) -
Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration
por: Dian, Ling-Hui, et al.
Publicado: (2018) -
Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer
por: Dong, Zhexu, et al.
Publicado: (2020)